A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors
Annals of Hematology · 2024-08 · 103 (8) · 3207-3217
DOI: 10.1007/s00277-024-05691-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 08.03.2024. Verfasst von Wenjie Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. Hauptthemen laut MEDLINE: Pharmacovigilance, Histone Deacetylase Inhibitors, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Science and Technology Program of Guangzhou.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. wwei9500@smu.edu.cn.
Förderung
- Science and Technology Program of Guangzhou
Zitieren
APA
Li, W., Fu, Y., & Wang, W. (2024). A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of Hematology, 103(8), 3207-3217. https://doi.org/10.1007/s00277-024-05691-2
Vancouver
Li W, Fu Y, Wang W. A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of Hematology. 2024;103(8):3207-3217. doi:10.1007/s00277-024-05691-2
BibTeX
@article{Li2024,
author = {Li, Wenjie and Fu, Yiming and Wang, Wei},
title = {A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors},
journal = {Annals of Hematology},
year = {2024},
volume = {103},
number = {8},
pages = {3207--3217},
doi = {10.1007/s00277-024-05691-2}
}
EUVIMED